Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125212432 | 12521243 | 2 | F | 20160725 | 20160701 | 20160803 | EXP | AU-SA-2016SA117753 | AVENTIS | POLASEK T.M., PERERA V., LUCIRE Y.SERIOUS ADVERSE DRUG REACTIONS TO ZOLPIDEM: DOES IMPAIRED METABOLIC CLEARANCE AND CONCURRENT SSRI/SNRI USE INCREASE RISK??J. PHARM. PRACT. RES.. 2016 JUN 01; 46(2):139-142. | 21.00 | YR | A | F | Y | 0.00000 | 20160803 | MD | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125212432 | 12521243 | 1 | PS | ZOLPIDEM TARTRATE. | ZOLPIDEM TARTRATE | 1 | Unknown | UNKNOWN | 19908 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125212432 | 12521243 | 1 | Insomnia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125212432 | 12521243 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125212432 | 12521243 | Accidental overdose | |
| 125212432 | 12521243 | Amnesia | |
| 125212432 | 12521243 | Physical assault | |
| 125212432 | 12521243 | Somnambulism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |